On Feb. 14, the U.S. Food and Drug Administration notified healthcare professionals and patients about a counterfeit version of Avastin 400 mg/16mL, which may have been purchased and used by some medical practices in the United State. The counterfeit version of Avastin does not contain the medicine’s active ingredient, bevacizumab. Read more.
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder